The Rise and Fall of Hipgnosis.
Securitisation made Simple.
What Merck Mercuriadis and Hipgnosis did was relatively simple: he took the source of a continuing stream of money from artists, put that anticipated amount together, then sold it on to investors at a higher price than he had bought that music from the artist. The artist got an upfront amount for his work, while investors got a secure stream of money going forward.
This 'repackaging' happens all the time in finance with car loans, credit card debt and yes, still today, with your mortgage loans, in spite of getting a very bad name during the Global Financial Crisis (GFC) in 2008. The logic to buyers of this 'packaging' is again simple: they get a secure stream of income over a defined period of time. Whereas the exact probability and time period financial maths is complicated, for the likes of companies with ongoing payment liabilities it's a dream come true: a secure income stream for many years to offset their current pay-outs, as in for example, an insurance company.
It's important to remember that financial markets are always looking to reverse what is known as the liability mismatch. Banks take in short term deposits (small amounts) and lend long term (big amounts). Any 'run on the bank' by the small amounts (those you and me situations: 'I want my money back now!') can blow-up the bank, since the long term amounts are locked up. Securitization, such as Hipgnosis, mainly reverses this: big amount upfront, small amounts paid out long term. Of course there is the possibility the 'big' amount will also do a runner, only that is much less likely, and another subject all together (and yes, I know banks lend many times more than their deposits, just trying to keep it simple!).
So when someone comes up with yet another big bunch of money that can be repackaged, all the buyers of 'big amounts' get very interested. Before you ask, yes there was a third leg to the why and the when Mercuriadis put this together: low interest rates. Once the concept got rolling, he could essentially 'front ran' the artists pay outs. Negotiations with, say Fleetwood Mac members or Justin Bieber, could feasibly (artists being artists) go on way longer than any financial buyer interest. Much easier to borrow funds for the artist pay-out at that low interest rate, repackage the song rights, and then on sell.
Who is Merck Mercuriadis?
At this juncture it's important to note that Merck Mercuriadis is a Canadian-born veteran music industry executive, and who had previously served as CEO of the Sanctuary Group (the parent company of Sanctuary Records Group). He had managed high-profile recording artists, including Elton John, Iron Maiden, Guns N' Roses, and Beyoncé, so he was in no way someone selling music securitization snake oil: he really does know the music business - although going into the details of the sale of this group to Universal music is a great way to appreciate how convoluted the whole industry is.
The Hipgnosis Hiccup #1
Here we come to the first, let's call it, Hipgnosis hiccup: very low interest rates. These made extremely easy to overpay a 'difficult' artist to get them on board (which major artist isn't difficult?). Equally, the end financial buyer would have difficulty in independently valuing the music rights stream, and would probably be relying on to a large extent on the seller (Mercuriadis) music knowledge. Then they would surely also have been blindsided by the whole 'celebrity musician' factor - "Neil Young?! Wow! He's HUGE! Yeah!! Let's do it!!!" Anyway, at that level financial engineering mostly comes down to interest rates spreads and rates of return. So as long as the financial math made sense, and the cover story certainly did, it was good to go.
Hipgnosis Songs Fund Limited lists on the London Stock Exchange
On July 11, 2018, Hipgnosis completed its Initial Public Offering on the Specialist Fund Segment of the London Stock Exchange's main market, successfully raising approximately £202 million (USD$ 265 million). Then, through a series of subsequent equity issues from April 2019 to September 2020, Hipgnosis amassed an additional £1.05 billion (US$1.3 billion) - a huge sum, even in this day of mega AI financing. Simply put, they sold bucket loads of new shares to yet more 'star struck' investors, enabling them to go on an artist buying spree. Amassing rights for Neil Young, Justin Bieber, Barry Manilow, Bon Jovi and many, many more, including 42 music catalogues from Kobalt Music Group, for which the Hipgnosis Songs Fund paid $322.9 million.
The Hipgnosis Hiccup #2
To explain further, the underlying business model is comprised of music mechanical rights, performance rights, and synchronization rights, and these do produce a solid, secure return stream for many years going forward. Only here we come to the Hipgnosis hiccup number two: for retail and institutional investors alike, the primary financial attraction of the buying Hipgnosis Songs Fund shares was its aggressive dividend policy: those small amounts being paid out to long term to shareholders from the music rights revenue streams. Only Hipgnosis was paying out far too much, largely to suck in yet more investors to issue yet more shares in order to purchase yet more artists rights at potentially inflated valuations.
In addition to paying rights dividends to shareholders, Hipgnosis had to pay interest on the loans it had also taken out via syndicated revolving credit facility (bank loan, to you and me), for around $600 to $700 million. This was manageable in a low interest rate environment, but when interest rates started to go up throughout 2022 and 2023 it became untenable. The Hipgnosis securitization to shareholders, to banks and rights holder's wheels started to fall off.
The NAV Disconnect.
By the autumn of 2023, the increasingly large disconnect between the fund's stated, internal Net Asset Value (estimated or implied value of all the music rights it owned) and its actual share price, triggered a crisis of confidence among its major institutional shareholders. This type of discrepancy in fund valuation nearly always means a seriously internal misevaluation.
Then the financial shenanigans started. By late 2023 the board of the London listed Hipgnosis Songs Fund proposed the sale of approximately one-fifth of the fund's total catalogue (roughly 29,000 songs) to its sister fund, Hipgnosis Songs Capital, for $440 million. Wait! what sister fund?! So here we arrive at Hipgnosis hiccup number three: the private sister fund (s).
The Sister(s) Fund.
Hipgnosis Songs Capital, was established in October 2021. It was owned and backed by private equity firm Blackstone which initially committed $1 billion to buying, yep, song rights. However, as part of this partnership, Blackstone also acquired an ownership stake in Hipgnosis Song Management itself.
Blackstone is primarily a private‑markets alternative asset manager and owner of assets, not to be confused with BlackRock. which is a public‑markets asset manager - similar names different market segments.
Naturally the London based share holders were not amused, as the Brits say. In markets speak is was widely seen as a steeply discounted (cheap) transfer of high-quality, cash-generating assets to a related party, orchestrated by a deeply conflicted investment advisor that sat on both sides of the transaction (Blackstone). On October 26, 2023, at an extraordinary general meeting (EGM), a majority voted overwhelming against securing a new five-year mandate for the fund to continue operating as an investment trust under its current structure, and they rejected the $440 million catalogue sale to Blackstone. The shareholder revolt essentially paralyzed the company's growth strategy and severed its access to public capital, so it ran out of money to operate.
On December 11, 2023, running out of money, the fund announced the sale of 20,000 unspecified "non-core" songs essentially back to the Kobalt Music Group (that, remember was part of the same group) , at $23.1 million at a 14% discount. The Brit shareholders were even less amused, and appointed Shot Tower Capital (a boutique investment banking firm located interestingly in Baltimore, Maryland) to conduct an exhaustive due diligence review and carry out an independent valuation of the assets.
The Shot Tower Capital Report.
The finding of Shot Tower Capital's review, published in early March 2024, fundamentally undermined Hipgnosis Song Management's previous financial reporting. The report cut the funds valuation from $2.6 billion six months prior, to a low of $1.83 Billion. In addition, the report identified a severe misrepresentation of ownership control, as the fund consistently implied it possessed greater ownership control and rights over its music assets than it legally held in practice. Music right ownership is extremely complicated: think deceased artists, recording label changes, co-song writers and much, much more.
And Shot Tower Capital found more: lapses in basic data integrity and corporate record-keeping, highly inconsistent financial data, and a damaging double-counting error regarding accrued revenue. In short a mess. And so everyone started suing everyone else. In yet another Hipgnosis name twist complication, liquidators of Hipgnosis Music Limited (note the name difference), a defunct, unlisted predecessor entity co-founded by Mercuriadis, filed a massive lawsuit in the High Court in London against the publicly listed Hipgnosis Songs Fund.
The Law Suits.
The Shot Tower Capital reports findings provoked an initial law suit from shareholders alleging Mercuriadis had abandoned the original venture, withdrew a planned 2017 prospectus, to establish the London-listed fund entirely for his own benefit. Mercuriadis then counter sued, alleging the original Hipgnosis Music Limited was secretly financed using the illicit proceeds (read money laundering) of a massive fraud against Swedish pension funds.
He claims that he was completely unaware of this criminal origin at the time, and on the discovering of the fraudulent backing forced him to abandon the original company to start over with clean financing. Only why he decided not to drop the Hipgnosis name is mystery, even more so as it is used for so many different legal entities as to be totally confusing.
The board of still listed company (Hipgnosis Song Management!) on seeing the threat of a potential legal liability, for which they was entirely uninsured, initiated legal action directly against its own investment advisor: the sued sue the sued!
This legal warfare effectively cut any remaining functional, cooperative relationship between the public board and the Blackstone-backed management team, setting the stage for a corporate takeover.
The End Game.
The chaos that had engulfed Hipgnosis Songs Fund ultimately made it precisely what private equity always looks for: a structurally broken vehicle sitting on top of genuinely valuable assets. The music catalogues had never stopped generating cash, so the dysfunction was entirely one of governance and debt, not of the underlying intellectual property. In the spring of 2024, a competitive bidding war erupted between two institutional giants: Concord Chorus, backed by Apollo Global Management, and Blackstone, which already owned the fund's own investment advisor. It was a structurally unequal contest. Blackstone's ownership of Hipgnosis Song Management gave it insider knowledge of the catalogues and, critically, a contractual right of counter-bid written into the original management agreement. There was really no contest.
On July 8, 2024, shareholders voted decisively to accept Blackstone's final offer of $1.31 per share, valuing the fund at $1.584 billion, a 49% premium to where the shares had traded before the process began, but at fraction of Hipgnosis Songs Fund's peak valuations . On July 30, 2024, Hipgnosis Songs Fund was delisted from the London Stock Exchange.
The experiment in publicly traded music securitization was over. Retail investors who had bought at the 2021 peak were left with heavy losses; a fitting, if brutal, end to a story that was always more about financial engineering than the love of music. Merck Mercuriadis stepped down as chairman of Hipgnosis Song Management on the same day, pivoting toward songwriter advocacy and a new private venture.
Blackstone and Sony Music.
Once free of the constraints of public markets and retail shareholders demanding quarterly dividends, Blackstone moved swiftly. The legacy Hipgnosis catalogues were merged with the assets of its private sister fund and quietly rebranded in March 2025 as Recognition Music Group, losing that Hipgnosis, which besides being just weird, had become toxic. In November 2024, Recognition priced a $1.47 billion asset-backed securitization deal, with ABS issuance of $372 million in July 2025, the first music securitization to carry a public rating from both Fitch and Standard & Poor's.
Private equity roll-up funds are rarely built to last. They are built to buy low, fix the structure, and sell high. Blackstone did exactly that. In early May 2026, Sony Music Publishing, partnered in a joint venture with GIC, Singapore's sovereign wealth fund, to acquire Recognition Music Group at a valuation of between $3.5 billion and $4.0 billion.
Hipgnosis may be no more, but its eight-year reign from disruptive IPO to billion-dollar privatisation to sovereign acquisition settled something that the music industry had long argued about: song catalogues are not a romantic abstraction. They are institutional-grade financial assets. Mercuriadis was right about that.
The songs remain. The artists will always play, only this type of high financial engineering and manoeuvring means bankers and music managers get paid, and the artists will still play for pennies.